Genetic Origin of Lipid Disorders

Lipid Disorder Clinical Trial

Official title:

Genetic Origin of Lipid Disorders

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT00277121
• Other study ID #: S-03150 (REK)
• Secondary ID: 02/4746 (SHdir)1
• Status: Not yet recruiting
• Phase: Phase 1
• First received: January 12, 2006
• Last updated: January 12, 2006
• Start date: January 2006

Study information

• Verified date: January 2006
• Source: University of Oslo
• Contact: Hilde Irene Nebb, PhD
• Phone: +47-22851510
• Email: h.i.nebb[@]medisin.uio.no
• Is FDA regulated: No
• Health authority: Norway: Regional Committee for Medical Research Ethics, Sothern Region (REK)Norway: Norwegian Social Science Data ServicesNorway: Directorate of Health
• Study type: Observational

Clinical Trial Summary

Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.

Description:

See "brief summary" above.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 0
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 54 Years

Eligibility

Inclusion Criteria:

• proven written informed consent prior to recruitment

• male or female

• 18-55 years old

• patients with severe lipid disorders

• fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range

Exclusion Criteria:

Study Design

Observational Model: Case Control, Time Perspective: Retrospective/Prospective

Related Conditions & MeSH terms

• Lipid Disorder
• Lipid Metabolism Disorders

Locations

Country	Name	City	State
Norway	Department of Nutrition, University of Oslo	Oslo

Sponsors (7)

Lead Sponsor	Collaborator
University of Oslo	CIGENE, Agricultural University of Norway, Aas, Norway, Hormone Laboratory, Aker University Hospital, Oslo, Norway, Lipid Clinic, The National Hospital, Oslo, Norway, Norwegian Institute of Public Health, Research Institute of Internal Medicine, The National Hospital, Oslo, Norway, Ullevaal University Hospital

Country where clinical trial is conducted

Norway,